Contains fulltext : 97513.pdf (publisher's version ) (Closed access)BACKGROUND: Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell counts below 0.350 x 10(9) cells/L initiate combined antiretroviral therapy (cART), but the optimal CD4 cell count at which cART should be initiated remains a matter of debate. OBJECTIVE: To identify the optimal CD4 cell count at which cART should be initiated. DESIGN: Prospective observational data from the HIV-CAUSAL Collaboration and dynamic marginal structural models were used to compare cART initiation strategies for CD4 thresholds between 0.200 and 0.500 x 10(9) cells/L. SETTING: HIV clinics in Europe and the Veterans Health Administration system in the ...
OBJECTIVE: To estimate the effect of combined antiretroviral therapy (cART) on mortality among HIV-i...
International audienceBACKGROUND: The CD4 cell count at which combination antiretroviral therapy sho...
International audienceBACKGROUND:Recommendations have differed nationally and internationally with r...
BACKGROUND: Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell co...
International audienceBACKGROUND: Most clinical guidelines recommend that AIDS-free, HIV-infected pe...
BACKGROUND: Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell co...
Background: Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell co...
BACKGROUND: CD4 cell count is a strong predictor of the subsequent risk of AIDS or death in HIV-infe...
Contains fulltext : 88938.pdf (publisher's version ) (Closed access)OBJECTIVE: To ...
Most adults infected with HIV achieve viral suppression within a year of starting combination antire...
OBJECTIVES: To compare the response to highly active antiretroviral therapy (HAART) in individuals s...
Objective: To illustrate an approach to compare CD4 cell count and HIV-RNA monitoring strategies in ...
OBJECTIVE: To evaluate CD4 cell count-driven strategies for the initiation of highly active antiretr...
Abstract OBJECTIVES: To compare the response to highly active antiretroviral therapy (HAART) in indi...
BACKGROUND: Recommendations have differed nationally and internationally with respect to the best ti...
OBJECTIVE: To estimate the effect of combined antiretroviral therapy (cART) on mortality among HIV-i...
International audienceBACKGROUND: The CD4 cell count at which combination antiretroviral therapy sho...
International audienceBACKGROUND:Recommendations have differed nationally and internationally with r...
BACKGROUND: Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell co...
International audienceBACKGROUND: Most clinical guidelines recommend that AIDS-free, HIV-infected pe...
BACKGROUND: Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell co...
Background: Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell co...
BACKGROUND: CD4 cell count is a strong predictor of the subsequent risk of AIDS or death in HIV-infe...
Contains fulltext : 88938.pdf (publisher's version ) (Closed access)OBJECTIVE: To ...
Most adults infected with HIV achieve viral suppression within a year of starting combination antire...
OBJECTIVES: To compare the response to highly active antiretroviral therapy (HAART) in individuals s...
Objective: To illustrate an approach to compare CD4 cell count and HIV-RNA monitoring strategies in ...
OBJECTIVE: To evaluate CD4 cell count-driven strategies for the initiation of highly active antiretr...
Abstract OBJECTIVES: To compare the response to highly active antiretroviral therapy (HAART) in indi...
BACKGROUND: Recommendations have differed nationally and internationally with respect to the best ti...
OBJECTIVE: To estimate the effect of combined antiretroviral therapy (cART) on mortality among HIV-i...
International audienceBACKGROUND: The CD4 cell count at which combination antiretroviral therapy sho...
International audienceBACKGROUND:Recommendations have differed nationally and internationally with r...